Published in Lab Business Week, September 23rd, 2007
The project was accomplished by integrating a patient's clinical data with tumor biomarker profiles and image analysis features using on-slide technologies and machine learning approaches developed at Aureon. Aureon Laboratories confirmed that specific clinical features appear associated with overall survival and has identified several protein biomarkers which appear important in predicting prognosis. The models provide further support to the utility of a...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Lab Business Week
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.